Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can generally take Mounjaro (tirzepatide) alongside a statin. No clinically significant drug interaction between tirzepatide and commonly prescribed statins has been identified, and many people in the Mounjaro clinical trials were already taking cholesterol-lowering medicines. That said, both medicines affect how your body processes fats, so your prescriber will want to review your full medication list before treatment begins — and periodically afterwards. These are prescription-only medicines, and a clinician decides whether the combination is right for you specifically.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misconception here is that statins and Mounjaro must clash because both medicines have effects on cholesterol and metabolic health. They don't interact in that sense. A drug interaction, in the clinical meaning, refers to one medicine changing how another is absorbed, broken down or excreted, not simply both affecting the same condition.
Tirzepatide works on GIP and GLP-1 receptors involved in appetite regulation and blood-sugar control. Statins work in the liver, blocking an enzyme involved in cholesterol synthesis. These are entirely different mechanisms, and the NHS's tirzepatide medicine page does not list statins among medicines that require special caution. The Mounjaro SmPC (the definitive clinical reference) notes that tirzepatide's slowing of gastric emptying has the theoretical potential to influence absorption of oral medicines, but real-world evidence and trial data have not flagged statins as a meaningful concern in practice.
If you take a statin and are considering Mounjaro for weight management, the honest answer is: the combination is widely used, well tolerated, and not contraindicated. What matters is that a prescriber reviews it properly, not that you avoid it.
Mounjaro slows the rate at which food leaves the stomach. For most oral medicines, this delays rather than reduces absorption, and for statins the clinical significance is low. Statins are typically taken at a fixed time each day regardless of meals (some are taken at night, some with food, some at any time, check your own leaflet). The delay in peak plasma levels caused by gastric slowing does not appear to change the medicine's effect over a 24-hour dosing cycle.
There is a more nuanced picture for medicines with narrow therapeutic windows (blood thinners, anti-epileptics, certain immunosuppressants) where timing and absorption consistency matter acutely. Statins are not in that category. That said, if you take atorvastatin specifically, there is more detailed information on the atorvastatin and Mounjaro question worth reading before your consultation.
The practical upshot: take your statin as usual. Tell your prescriber you take it. They'll note it. That's the process.
This is where the combination gets genuinely interesting, and where monitoring matters. Tirzepatide produces meaningful reductions in body weight for many people, and sustained weight loss tends to improve lipid profiles: LDL cholesterol, triglycerides and non-HDL cholesterol often fall. In SURMOUNT-1, the pivotal phase 3 trial published in the New England Journal of Medicine, participants at the higher doses saw significant improvements in cardiovascular risk markers alongside weight reduction.
If your lipid levels improve substantially on Mounjaro, your GP may want to reassess whether you still need the same statin dose, or the same statin at all. That's a good problem to have, but it means regular blood tests become more important, not less. Don't adjust or stop your statin without speaking to your GP or prescriber first. The decision belongs with the clinician who has your full picture.
For broader context on how Mounjaro affects other aspects of cardiovascular health, the dedicated Mounjaro and statins page goes into the lipid evidence in more depth. Cost of treatment is a separate practical question; you can read about Mounjaro pricing in the UK if that's on your mind. And if you're also taking HRT, the guidance on Mounjaro and HRT covers an interaction that does require more specific attention than statins do.
At any legitimate online pharmacy (and certainly at ours at nume) your consultation is reviewed by a GPhC-registered Independent Prescriber who reads your full medication history before making any prescribing decision. Not a form-checking algorithm. A named clinician.
For statins specifically, what helps them: the name of the statin, the dose, how long you've been taking it, and your most recent cholesterol result if you have it. If you've had a recent lipid panel, mention it. It lets the prescriber make a more informed call, and it may shorten the back-and-forth.
People often ask whether they need to stop their statin before starting Mounjaro. You don't. There's no washout period, no compatibility test, no timing protocol required. Start Mounjaro as prescribed; continue the statin as prescribed; let your GP know you've started a new medicine so your annual review accounts for it. It's also worth knowing that some people find the combination leads to faster improvement in their cholesterol numbers than statin alone, another reason to keep up with blood tests rather than skip them.
Questions about other medicines that do require closer attention (including GLP-1 medicines taken alongside other GLP-1 treatments) are covered separately. Our clinical team is available seven days a week for aftercare queries once you're a patient; you can reach us through the contact page.
If you're ready to talk through your full medication list and check your suitability, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.